• Applied Use of BV6: Optimizing IAP Antagonism in Cancer Mode

  2026-04-22

  BV6 is a selective IAP antagonist enabling robust apoptosis induction and radiosensitization in cancer and endometriosis models. This guide delivers actionable, evidence-based workflows, protocol refinements, and troubleshooting strategies to maximize the translational impact of BV6 from APExBIO.

• Citron OGD2 Drives Iron- and ROS-Linked Defense Against Citr

  2026-04-22

  This study uncovers how CmOGD2, a 2-oxoglutarate-dependent dioxygenase in Citron, orchestrates resistance to citrus canker via enhanced iron uptake and ROS-triggered ferroptosis. The work reveals a negative feedback loop involving CmENO2 and CmZAT10.1, and details how Xanthomonas effectors subvert this pathway, offering new targets for plant immunity research.

• Nile Red for Quantitative Lipid Dynamics: Protocols and Prog

  2026-04-21

  Discover how Nile Red enables next-generation intracellular lipid droplet staining and lipid metabolism research. This cornerstone guide combines rigorous protocol insights, new perspectives on lipid pathway analysis, and translational implications drawn from recent biomarker discoveries.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-04-21

  This study uncovers how carcinogen-induced super-enhancer RNA (seRNA-NPCm) promotes metastasis in nasopharyngeal carcinoma (NPC) by modulating the NPM1/c-Myc/NDRG1 transcriptional axis. The findings offer fresh mechanistic insight into enhancer-mediated gene regulation in cancer and inform new approaches for biomarker discovery and therapeutic intervention.

• VX-745: Selective p38α MAPK Inhibitor for Translational Rese

  2026-04-20

  VX-745, a highly selective p38α MAPK inhibitor, empowers researchers to dissect inflammatory and oncogenic pathways with nanomolar precision. Unique dual-action mechanisms and robust protocol flexibility make it a cornerstone for advanced cell signaling, multiple myeloma, and arthritis models.

• Brefeldin A (BFA): Scenario-Driven Solutions for ER Stress A

  2026-04-20

  This article addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assays, showing how Brefeldin A (SKU B1400) offers reproducible, evidence-based solutions for ER stress and apoptosis research. Drawing on validated data and practical Q&A, we demonstrate why APExBIO’s Brefeldin A is a reliable tool for modern biomedical labs.

• 7-Ethyl-10-hydroxycamptothecin: Advanced Colon Cancer Resear

  2026-04-19

  Leverage 7-Ethyl-10-hydroxycamptothecin (SN-38) for robust, dual-action workflows in advanced colon cancer research. This guide details optimized protocols and troubleshooting strategies—empowering reliable in vitro results by integrating recent mechanistic insights from FUBP1 pathway disruption.

• DiscoveryProbe Bioactive Compound Library Plus: Workflow-Dri

  2026-04-18

  The DiscoveryProbe™ Bioactive Compound Library Plus empowers translational researchers with 5,072 rigorously validated, cell-permeable bioactive small molecules—each pre-dissolved for immediate use in high-throughput screening. This article details how to leverage SKU L1022P for advanced pathway, apoptosis, and cancer research, with actionable protocol enhancements and troubleshooting strategies grounded in recent ligand screening advances.

• Palomid 529 (P529): Precision PI3K/Akt/mTOR Inhibition in ES

  2026-04-17

  Explore how Palomid 529 (P529) enables targeted PI3K/Akt/mTOR pathway inhibition in esophageal squamous cell carcinoma (ESCC) models. This article uniquely connects mechanistic insights with assay protocols, revealing how P529 advances cancer research and radiotherapy enhancement.

• EGTA in Calcium Signaling: Optimizing Neuroprotection & Infl

  2026-04-16

  EGTA (egtazic acid) empowers researchers to dissect calcium-dependent mechanisms with precision, offering selective chelation in neuroprotection and vascular inflammation models. This article provides actionable protocols, advanced applications, and troubleshooting strategies for using EGTA in experimental workflows.

• A 83-01 ALK-5 Inhibitor: Precision Tools for Organoid & EMT

  2026-04-15

  A 83-01, a selective ALK-5 inhibitor from APExBIO, empowers researchers to fine-tune TGF-β pathway control in organoid modeling and EMT workflows. This article translates cutting-edge reference findings into practical, stepwise protocols and troubleshooting guidance, ensuring robust, reproducible results in advanced cellular research.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-04-14

  This study establishes moesin (MSN) as a novel serum biomarker for evaluating endothelial injury in sepsis. By integrating patient data, animal models, and in vitro assays, the research demonstrates that MSN correlates with disease severity and mechanistically contributes to vascular dysfunction, advancing both diagnostic and mechanistic understanding.

• Neurotensin: Precision Tool for GPCR Trafficking Mechanism S

  2026-04-13

  Neurotensin (CAS 39379-15-2) is the benchmark Neurotensin receptor 1 activator for dissecting GPCR trafficking and miRNA regulation workflows. APExBIO’s high-purity formulation ensures reproducibility and minimal interference, empowering rigorous gastrointestinal and neural cell research.

• HAX1 Controls SARS-CoV-2 Spike-Induced ER Stress and UPR Act

  2026-04-13

  This study identifies HAX1 as a crucial mediator of the unfolded protein response (UPR) triggered by the SARS-CoV-2 spike protein in host cells. The findings reveal a unique HAX1-dependent mechanism for handling spike-induced ER stress, with implications for understanding viral pathogenesis and cellular stress regulation.

• Comparative Antibacterial Activity of Cefoperazone and β-Lac

  2026-04-12

  This article examines a seminal comparative study evaluating the antibacterial efficacy of N-formimidoyl thienamycin (MK0787) against a panel of recently developed β-lactam antibiotics, including cefoperazone. The findings clarify cefoperazone's spectrum, β-lactamase stability, and its role in benchmarking gram-negative resistance research.

16256 records 1/1084 page Next 12345 下5页 Last page